Implementation of risk-sharing agreement in patients with lung cancer treated with immunotherapy based on RWD in the Czech Republic

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	BÁRTOVÁ Adéla ŘÍHOVÁ Barbora
Year of publication	2023
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	This analysis aimed to assess the impact of risk-sharing agreements on budgetary considerations and immunotherapy treatment outcomes for locally advanced and metastatic NSCLC in the Czech Republic.
Related projects:	CZECRIN - Czech National Node to the European Clinical Research Infrastructure Network Preclinical and clinical research of the Department of Pharmacology in the field of biotransformation of drugs, behavioural neuropsychopharmacology and personalized pharmacotherapy in oncology